Discover effective solutions for migraines through chiropractic rehabilitation for better pain management and relief.
Table of Contents
Abstract
Migraine is a complex primary neurological disorder characterized by recurrent attacks of moderate-to-severe head pain accompanied by sensory, autonomic, and cognitive symptoms. This educational post, written by Dr. Alexander Jimenez, DC, APRN, FNP-BC, CFMP, IFMCP, ATN, CCST, explains the physiological underpinnings of migraine across its phases, the full range of symptoms, and the profound effects on day-to-day functioning, work, relationships, and mental health. It presents the latest findings from leading researchers using modern evidence-based methods, including the role of the trigeminovascular system, calcitonin gene-related peptide (CGRP), cortical spreading depression, and central sensitization. The post details how integrative chiropractic care, when combined with medical oversight, functional medicine, physical therapy, massage, lifestyle strategies, and appropriate pharmacologic options such as onabotulinumtoxinA (Botox) for chronic migraine, can support individuals as part of a comprehensive health and wellness routine. Clinical observations from Dr. Jimenez’s practice at Injury Medical Clinic PA (also known as Mission Plaza Injury Medical Clinic) in El Paso, Texas, are incorporated, along with the collaborative role of Dr. Maria Guadalupe Cardenas, MD (Board Certified in Internal Medicine, NPI #1164426749, Texas MD License #J2933), who serves as Medical Director and Collaborative Physician. The goal is to provide clear, actionable understanding so readers can work with qualified clinicians to reduce attack burden through non-surgical, multidisciplinary care.
What Migraine Is and How It Affects the Body
Migraine is far more than a severe headache. It is a genetically influenced, environmentally modulated disorder of sensory processing in which the brain becomes hyperexcitable and the trigeminovascular system is activated, leading to the release of inflammatory neuropeptides such as CGRP and pituitary adenylate cyclase-activating polypeptide (PACAP) (Ashina, 2020; Goadsby et al., 2017). The result is a cascade that produces throbbing or pulsating pain, typically unilateral but often bilateral, lasting 4 to 72 hours if untreated, and accompanied by nausea, vomiting, photophobia, phonophobia, and osmophobia.
The pathophysiology begins with activation of the trigeminovascular system. Trigeminal nerve sensory fibers innervate the meninges and cranial blood vessels. When these fibers are activated, they release CGRP, which causes vasodilation, plasma protein extravasation, and neurogenic inflammation. Second-order neurons in the trigeminocervical complex (TCC) in the upper cervical spinal cord and lower brainstem receive convergent input from the trigeminal nerve and the upper cervical nerves (C1–C3). This anatomical convergence explains why neck pain and stiffness are reported by the majority of people with migraine, often before or during the headache phase, and why dysfunction in the upper cervical spine can amplify or trigger attacks in susceptible individuals (Bartsch & Goadsby, 2003; Noseda & Burstein, 2013).
Central sensitization further magnifies the experience. Repeated activation lowers the pain threshold, producing allodynia (pain from normally non-painful stimuli such as light touch or hair brushing) and increased disability. Hypothalamic and brainstem nuclei are involved in the premonitory phase, while cortical spreading depression underlies aura in those who experience it. The older vascular theory of migraine has been superseded; vasodilation is secondary, not the primary cause.
Comorbidities that commonly affect people with migraine include anxiety, depression, sleep disorders, and, in some cases, cardiovascular risk factors. These conditions interact with the same neural networks that drive migraine, amplifying both frequency and disability (Lipton et al., 2003; Global Burden of Disease studies summarized in Ashina, 2020).
The Phases of a Migraine Attack and Their Physiological Basis
A typical attack progresses through overlapping phases. Understanding each phase clarifies why symptoms feel the way they do and why early recognition matters.
Prodrome or Premonitory Phase
In up to 77% of individuals, symptoms appear hours to two days before the headache. These include mood changes, yawning, fatigue, neck stiffness or pain, food cravings, and changes in appetite or thirst. Physiologically, this phase is linked to hypothalamic activation and dopaminergic fluctuations. The hypothalamus regulates circadian rhythms, feeding, and autonomic function; its early involvement explains why sleep disruption or irregular meals so often precede attacks. Neck pain in this phase frequently arises from the TCC convergence rather than primary musculoskeletal injury, although concurrent cervical dysfunction can intensify the signal.
Aura Phase
Approximately one-third of people with migraine experience aura, most often visual (scintillating scotoma, fortification spectra) but sometimes sensory, language, or motor. Cortical spreading depression produces aura: a slowly propagating wave of neuronal depolarization followed by suppression that travels across the cortex at 2–6 mm per minute. This wave activates the trigeminovascular system and, in many cases, contributes to the subsequent headache. Aura symptoms are fully reversible and typically last 5–60 minutes.
Headache Phase
Peripheral sensitization of meningeal nociceptors and central amplification in the TCC and higher centers generate the pain. CGRP release is a key mediator; blocking CGRP or its receptor with monoclonal antibodies or gepants reduces attack frequency and severity in many patients. Associated symptoms arise from the same network: nausea and vomiting from brainstem autonomic involvement, photophobia and phonophobia from heightened sensory gain, and cognitive slowing from temporary disruption of attention and processing networks. Routine physical activity aggravates the pain because movement increases intracranial pressure and sensory input.
Postdrome Phase
After the pain subsides, many people feel exhausted, mentally foggy, or emotionally flat for up to 48 hours. Residual hyperexcitability and the metabolic cost of the attack produce this “migraine hangover.” Cognitive symptoms during and after the attack explain why presenteeism (reduced productivity while at work) is often greater than absenteeism.
Symptoms of Migraines and How They Manifest
Symptoms vary widely but share common features defined by the International Classification of Headache Disorders, 3rd edition (ICHD-3).
- Unilateral or bilateral moderate-to-severe throbbing pain lasting 4–72 hours
- Nausea and/or vomiting
- Photophobia, phonophobia, and sometimes osmophobia
- Aggravation by routine physical activity
- Prodromal neck pain or stiffness in the majority of patients
- Aura in about 30% of cases
- Allodynia in many with frequent attacks
- Cognitive impairment (difficulty concentrating, word-finding difficulty) during and between attacks
- Autonomic features such as lacrimation or nasal congestion in some individuals
These symptoms are not merely uncomfortable; they force behavioral changes. The person retreats to a dark, quiet room because sensory input is amplified. Family and work responsibilities are interrupted. Over time, anticipating the next attack becomes a stressor that can lower the threshold for future attacks.
How Migraines Affect Day-to-Day Life and the Person
Migraine ranks among the leading causes of years lived with disability worldwide, particularly in adults under age 50 and especially in women (Global Burden of Disease data cited in Ashina, 2020; Steiner et al.). Attacks disrupt every domain of life.
At work, both absenteeism and presenteeism occur. Studies estimate tens of millions of lost workdays annually in large economies; many people reduce hours or leave the workforce. Cognitive symptoms and the need to manage sensory triggers reduce performance even on “good” days. Family life is affected when a parent cannot participate in activities or when children learn to be quiet during attacks. Social isolation grows because plans are canceled. Mental health suffers; rates of anxiety and depression are substantially elevated, creating a bidirectional relationship in which mood disorders both result from and worsen migraine frequency (Lipton et al., 2003).
Interictal burden is equally important. Between attacks, people may experience residual fatigue, sleep disruption, and anxiety about the next attack. Lifestyle is restricted to avoid triggers. Medication overuse headache can develop if acute treatments are used too frequently, further complicating the picture. The cumulative effect is reduced quality of life, lower self-efficacy, and, in chronic migraine (?15 headache days per month for >3 months, with ?8 migraine days), marked disability.
Migraine Pain Treatment El Paso, TX Chiropractor- Video
Integrative Chiropractic Care Within Non-Surgical Migraine Management
Chiropractic care does not replace the diagnosis or primary pharmacologic management of migraine, which is a neurological disorder. However, because the majority of people with migraine report neck pain and because of the anatomical convergence at the trigeminocervical complex, addressing concurrent cervical musculoskeletal dysfunction can reduce one potential amplifier of the attack cascade (Bartsch & Goadsby, 2003). Systematic reviews of spinal manipulative therapy for migraine show mixed and generally low-certainty evidence for reduction in migraine days or intensity when used in isolation; some earlier meta-analyses suggested small effects, while more recent analyses rate certainty as low or very low and call for larger, higher-quality trials (Rist et al., 2019; subsequent 2024 updates). Multimodal chiropractic approaches that include soft-tissue work, mobilization, exercise, posture education, and lifestyle advice appear more promising than manipulation alone.
In clinical practice, Dr. Jimenez has observed that patients who present with high-frequency migraine plus neck pain, forward-head posture, and suboccipital or upper-trapezius myofascial tenderness often report fewer headache days and lower intensity when cervical mobilization or low-force techniques are combined with sleep stabilization, hydration, and optimized acute medications. The reasoning is physiological: reducing nociceptive input from C1–C3 into the TCC may decrease the overall excitability of second-order neurons that also receive trigeminal input. This is not claimed as a cure for the underlying neurological disorder, but as a supportive strategy for the musculoskeletal contribution present in many individuals.
Physical therapy focuses on graded cervical and scapular stabilization exercises, improving deep neck flexor endurance, and correcting posture. Massage therapy and myofascial release can decrease local muscle hypertonicity and improve circulation. Functional wellness approaches address sleep hygiene, stress regulation, nutrition, and micronutrient status (for example, magnesium or riboflavin where deficiency or clinical response supports their use). These non-surgical modalities are additive; they do not replace evidence-based acute or preventive medications when those are indicated.
How Botox Helps with Migraines and Clinical Guidelines
OnabotulinumtoxinA (Botox) is FDA-approved for the prevention of chronic migraine in adults. It is not indicated for episodic migraine. Chronic migraine is defined as headache on 15 or more days per month for more than three months, with at least eight of those days meeting migraine criteria or responding to migraine-specific treatment (American Migraine Foundation).
Botox is injected into shallow muscles around the head and neck in a standardized pattern of approximately 31 sites (PREEMPT protocol, total 155 units). The toxin enters nerve endings and inhibits the release of pain-related neurotransmitters, including CGRP, from peripheral trigeminal sensory fibers. This reduces activation of the central pain networks. Benefits typically increase over the second and third treatment cycles; each cycle lasts about 10–12 weeks. In the pivotal PREEMPT trials, patients experienced an average reduction of roughly 8–9 headache days per month versus a smaller reduction with placebo (American Migraine Foundation; Dodick et al.).
Insurance coverage commonly requires failure of at least two other preventive medications. Clinicians experienced with the protocol perform the treatment. The most common side effect is transient neck soreness. Botox can be combined with other non-surgical strategies and does not interact with most oral migraine medications. Assess response after about 24 weeks (two to three cycles).
Home Strategies to Reduce Migraine Frequency and Severity
Lifestyle consistency is foundational. The mnemonic SEEDS (sleep, exercise, eat, diary, stress) summarizes evidence-informed steps (American Migraine Foundation; Mayo Clinic guidance).
- Sleep: Maintain consistent bed and wake times. Aim for the number of hours that leaves the individual rested (commonly 7–8). Avoid long daytime naps.
- Exercise: 30–50 minutes of moderate aerobic activity most days of the week can reduce frequency for many people by elevating endorphins and improving sleep and stress resilience. Start gradually if exercise triggers symptoms.
- Eat and hydrate: Eat regular meals, drink enough water, and avoid prolonged fasting. Identify and limit personal food triggers via a diary. Some individuals benefit from higher omega-3 intake or addressing micronutrient shortfalls under clinician guidance.
- Diary: Track attacks, potential triggers, medication use, and response. This improves diagnosis and treatment decisions.
- Stress: Relaxation training, biofeedback, mindfulness, or cognitive-behavioral approaches lower overall excitability.
Additional practical steps include resting in a dark, quiet room at the first sign of an attack, applying cold or heat packs to the head or neck, and using small amounts of caffeine early in an attack if it is not a personal trigger. These measures support but do not replace medical care.
The Multidisciplinary Team at Injury Medical Clinic PA
At Injury Medical Clinic PA in El Paso, Texas, we deliver integrative care under medical direction. Dr. Maria Guadalupe Cardenas, MD, Board Certified in Internal Medicine with more than 40 years of experience as an internist (NPI #1164426749, Texas MD License #J2933), serves as Medical Director and Collaborative Physician. This structure is common in integrative and personal-injury clinics: the physician provides medical oversight, coordinates diagnostic work-up, manages pharmacologic therapy when indicated, and ensures that non-surgical approaches remain within appropriate safety boundaries.
Dr. Jimenez, as the chiropractic and advanced-practice clinician, evaluates the neuromusculoskeletal contribution, delivers hands-on care, and collaborates on functional-medicine and rehabilitation plans. The team integrates chiropractic care, functional medicine assessments, physical rehabilitation, and, when appropriate, referral for interventional options such as Botox performed by qualified providers. Personal-injury cases receive coordinated documentation and care that addresses both the acute injury and any pre-existing or concurrent migraine burden. The shared goal is to reduce attack frequency, lower disability, and restore function through the least invasive effective combination of strategies.
Reasoning Behind Each Component of Care
Each element is chosen for a physiological rationale. Cervical techniques aim to decrease nociceptive drive into the TCC. Exercise and sleep regulation stabilize hypothalamic and autonomic output that influences attack threshold. Magnesium and riboflavin are used when clinical or laboratory data support them because they participate in mitochondrial energy metabolism and neuronal membrane stability. Botox is reserved for chronic migraine that has not responded adequately to other preventives because its mechanism targets peripheral CGRP release in a manner supported by large randomized trials. Medical oversight ensures that red-flag symptoms are excluded, medication overuse is identified, and comorbidities such as depression or sleep apnea are addressed.
Clinical observations in the El Paso practice show that patients who engage consistently with the multimodal plan—medical management when needed, cervical and soft-tissue care, lifestyle stabilization, and home strategies—most often report meaningful reductions in headache days and improved daily function. Individual responses vary; careful tracking and shared decision-making remain essential.
Conclusion
Migraine is a disabling neurological condition whose physiological mechanisms are increasingly well understood. By recognizing the phases, symptoms, and impact on daily life, individuals can partner with clinicians who offer both evidence-based pharmacologic options and supportive non-surgical care. Integrative chiropractic approaches that respect the limits of current evidence, combined with medical direction from an experienced internist such as Dr. Cardenas, functional wellness, physical therapy, and proven home strategies, form a practical pathway toward fewer attacks and better quality of life. Readers are encouraged to seek personalized evaluation from qualified healthcare professionals.
References
- American Migraine Foundation. (n.d.). Botox for migraine.
- Ashina, M. (2020). Migraine. New England Journal of Medicine, 383(19), 1866–1876.
- Bartsch, T., & Goadsby, P. J. (2003). The trigeminocervical complex and migraine: Current concepts and synthesis. Current Pain and Headache Reports, 7(5), 371–376.
- Goadsby, P. J., Holland, P. R., Martins-Oliveira, M., Hoffmann, J., Schankin, C., & Akerman, S. (2017). Pathophysiology of migraine: A disorder of sensory processing. Physiological Reviews, 97(2), 553–622.
- Lipton, R. B., Bigal, M. E., Diamond, M., Freitag, F., Reed, M. L., & Stewart, W. F. (2007). Migraine prevalence, disease burden, and the need for preventive therapy. Neurology, 68(5), 343–349.
- Mayo Clinic. (n.d.). Migraines: Simple steps to head off the pain.
- Noseda, R., & Burstein, R. (2013). Migraine pathophysiology: Anatomy of the trigeminovascular pathway and associated neurological symptoms, CSD, sensitization and modulation of pain. Pain, 154(Suppl 1), S44–S53.
- Rist, P. M., Hernandez, A., Bernstein, C., Kowalski, M., Osypiuk, K., Vining, R., … & Wayne, P. M. (2019). The impact of spinal manipulation on migraine pain and disability: A systematic review and meta-analysis. Headache, 59(4), 532–542.
SEO tags: migraine pathophysiology, chronic migraine treatment, Botox for migraines, chiropractic care for migraine, trigeminocervical complex, non-surgical migraine management, integrative chiropractic El Paso, Dr. Alexander Jimenez migraine, lifestyle strategies for migraine, CGRP and migraine, neck pain and migraine, functional medicine migraine support, Dr. Maria Guadalupe Cardenas, Injury Medical Clinic PA, evidence-based migraine care
